Mingxia Wang

Shenzhen Key Laboratory Of Male Reproductive Medicine And Genetics
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Screening and characterization of DNA aptamers that modulate prime editing.

Screening and characterization of DNA aptamers that modulate prime editing.

Journal: Frontiers in molecular biosciences

Published: January 23, 2025

Tumor-derived exosomal KPNA2 activates fibroblasts and interacts with KIFC1 to promote bladder cancer progression, a process inhibited by miR-26b-5p.

Tumor-derived exosomal KPNA2 activates fibroblasts and interacts with KIFC1 to promote bladder cancer progression, a process inhibited by miR-26b-5p.

Journal: Cellular & molecular biology letters

Published: July 09, 2024

Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms.

Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms.

Journal: International journal of nanomedicine

Published: January 07, 2024

CRISPR applications in cancer diagnosis and treatment.

CRISPR applications in cancer diagnosis and treatment.

Journal: Cellular & molecular biology letters

Published: May 11, 2023

Synthetic Circular gRNA Mediated Biological Function of CRISPR-(d)Cas9 System.

Synthetic Circular gRNA Mediated Biological Function of CRISPR-(d)Cas9 System.

Journal: Frontiers in cell and developmental biology

Published: January 27, 2022

Screening DNA aptamers that control the DNA cleavage, homology-directed repair, and transcriptional regulation of the CRISPR-(d)Cas9 system.

Screening DNA aptamers that control the DNA cleavage, homology-directed repair, and transcriptional regulation of the CRISPR-(d)Cas9 system.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 14, 2021

Synthesis of RNA-based gene regulatory devices for redirecting cellular signaling events mediated by p53.

Synthesis of RNA-based gene regulatory devices for redirecting cellular signaling events mediated by p53.

Journal: Theranostics

Published: November 13, 2020

A Light-Inducible Split-dCas9 System for Inhibiting the Progression of Bladder Cancer Cells by Activating p53 and E-cadherin.

A Light-Inducible Split-dCas9 System for Inhibiting the Progression of Bladder Cancer Cells by Activating p53 and E-cadherin.

Journal: Frontiers in molecular biosciences

Published: November 10, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026